APA (7th ed.) Citation

Valgimigli, M., Costa, F., Lokhnygina, Y., Clare, R. M., Wallentin, L., Moliterno, D. J., . . . Tricoci, P. (2017). Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: Lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. European heart journal, 38(11), ehw525-810. https://doi.org/10.1093/eurheartj/ehw525

Chicago Style (17th ed.) Citation

Valgimigli, Marco, et al. "Trade-off of Myocardial Infarction Vs. Bleeding Types on Mortality After Acute Coronary Syndrome: Lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) Randomized Trial." European Heart Journal 38, no. 11 (2017): ehw525-810. https://doi.org/10.1093/eurheartj/ehw525.

MLA (9th ed.) Citation

Valgimigli, Marco, et al. "Trade-off of Myocardial Infarction Vs. Bleeding Types on Mortality After Acute Coronary Syndrome: Lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) Randomized Trial." European Heart Journal, vol. 38, no. 11, 2017, pp. ehw525-810, https://doi.org/10.1093/eurheartj/ehw525.